Kaisa Lehtio - Publications

KaSARi: a national framework for standardized, automated, and predictive radiotherapy in Finland.

Journal: Acta oncologica (Stockholm, Sweden)

Published: March 10, 2026

Dental, mandibular and parotid gland radiation doses in curatively treated head and neck squamous cell carcinoma: a retrospective cohort study.

Journal: BDJ open

Published: September 07, 2025

Improved brain tumor diagnostics and follow-up with novel magnetic resonance imaging methods: A single center study protocol.

Journal: PloS one

Published: July 24, 2025

Multicentre evaluation of deep learning CT autosegmentation of the head and neck region for radiotherapy.

Journal: NPJ digital medicine

Published: November 26, 2024

Changes in the use of chemoradiotherapy for non-small cell lung cancer after guideline implementation in Finland between 2016 and 2020.

Journal: Cancer treatment and research communications

Published: July 08, 2024

Hypopharyngeal carcinoma in Finland from 2005 to 2014: outcome remains poor after major changes in treatment.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: May 18, 2022

Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma.

Journal: Acta oncologica (Stockholm, Sweden)

Published: December 31, 2021

A Deep Learning-Based Automated CT Segmentation of Prostate Cancer Anatomy for Radiation Therapy Planning-A Retrospective Multicenter Study.

Journal: Diagnostics (Basel, Switzerland)

Published: September 23, 2020

Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.

Journal: BMC cancer

Published: January 07, 2014

Prognostic value of tumour blood flow, [¹⁸F]EF5 and [¹⁸F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 31, 2013

In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 13, 2013

Plasma pharmacokinetics, whole-body distribution, metabolism, and radiation dosimetry of 68Ga bombesin antagonist BAY 86-7548 in healthy men.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: April 09, 2013